Stock RVNC REVANCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart Revance Therapeutics, Inc.

Equities

RVNC

US7613301099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
3.32 USD -22.61% Intraday chart for Revance Therapeutics, Inc. -15.95% -62.23%
May. 10 Needham Adjusts Price Target on Revance Therapeutics to $12 From $18, Maintains Buy Rating MT
May. 10 Piper Sandler Cuts Price Target on Revance Therapeutics to $11 From $20, Maintains Overweight Rating MT
Chart Revance Therapeutics, Inc.
  1. Stock Market
  2. Equities
  3. RVNC Stock
  4. Charts Revance Therapeutics, Inc.
  5. Static Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW